Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Haematologica|October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologiesGiovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.
Haematologica|November 24, 2018
Trypsin-encoding <i>PRSS1-PRSS2</i> variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group reportBenjamin O Wolthers, Thomas L Frandsen, Chirag J Patel, et al.
British Journal of Haematology|June 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group StudyStavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Leukemia|May 18, 2022
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolutionPaulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, et al.
EMBO Molecular Medicine|August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursorsBüşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.
Trials|September 8, 2024
Effectiveness of structured, multidisciplinary long-term care for pediatric cancer survivors: protocol of the multicenter, randomized-controlled AELKI studyHannah Schmidt, Katja Baust, Gabriele Calaminus, et al.
Molecular Oncology|June 21, 2022
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemiaMireia Ramos-Muntada, Juan L Trincado, Joan Blanco, et al.
Blood Advances|October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
Pageof 14